These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22418889)

  • 21. Hepatic lipid metabolism in exercise and training.
    Gorski J; Oscai LB; Palmer WK
    Med Sci Sports Exerc; 1990 Apr; 22(2):213-21. PubMed ID: 2192222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The trials and tribulations of the treatment of nonalcoholic fatty-liver disease.
    Gan SK; Adams LA; Watts GF
    Curr Opin Lipidol; 2008 Dec; 19(6):592-9. PubMed ID: 18957882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic strategies in nonalcoholic fatty liver disorders.
    Poordad FF
    Expert Opin Emerg Drugs; 2005 May; 10(2):237-9. PubMed ID: 15934865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of metabolic syndrome in children and adolescents.
    Pacifico L; Anania C; Martino F; Poggiogalle E; Chiarelli F; Arca M; Chiesa C
    Nutr Metab Cardiovasc Dis; 2011 Jun; 21(6):455-66. PubMed ID: 21565479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of intermittent exercise on adiposity and fatty liver in rats fed with high-fat diet.
    Sene-Fiorese M; Duarte FO; Scarmagnani FR; Cheik NC; Manzoni MS; Nonaka KO; Rossi EA; de Oliveira Duarte AC; Dâmaso AR
    Obesity (Silver Spring); 2008 Oct; 16(10):2217-22. PubMed ID: 18719640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach.
    Bellentani S; Dalle Grave R; Suppini A; Marchesini G;
    Hepatology; 2008 Feb; 47(2):746-54. PubMed ID: 18098321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease: a review.
    Poordad FF
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):661-70. PubMed ID: 16083334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
    Lee YS; Kek BL; Poh LK; Saw SM; Loke KY
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):172-8. PubMed ID: 18664869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.
    Cortez-Pinto H; Machado M
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):217-31. PubMed ID: 19072357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
    Tessari P; Coracina A; Cosma A; Tiengo A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver fat and lipid oxidation in humans.
    Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
    Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does physical inactivity cause nonalcoholic fatty liver disease?
    Rector RS; Thyfault JP
    J Appl Physiol (1985); 2011 Dec; 111(6):1828-35. PubMed ID: 21565984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of non-alcoholic fatty liver disease].
    Koek GH
    Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fat change in obese children after a 1-year nutrition-behavior intervention.
    Pozzato C; Verduci E; Scaglioni S; Radaelli G; Salvioni M; Rovere A; Cornalba G; Riva E; Giovannini M
    J Pediatr Gastroenterol Nutr; 2010 Sep; 51(3):331-5. PubMed ID: 20562718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
    Larter CZ; Chitturi S; Heydet D; Farrell GC
    J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid metabolism in the liver.
    Canbay A; Bechmann L; Gerken G
    Z Gastroenterol; 2007 Jan; 45(1):35-41. PubMed ID: 17236119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.
    Suzuki A; Lindor K; St Saver J; Lymp J; Mendes F; Muto A; Okada T; Angulo P
    J Hepatol; 2005 Dec; 43(6):1060-6. PubMed ID: 16140415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment strategies in nonalcoholic fatty liver disease.
    Tilg H; Kaser A
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):148-55. PubMed ID: 16265156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.